What works for statin hesitancy

In cardiology clinic, I use the ACC/AHA ASCVD Risk Estimator app and a 90-second visual explanation to recommend a moderate-intensity statin, but I’m not convinced it sticks once they’re home. What phrasing or take-home aids have moved the needle for you on statin hesitancy when LDL sits around [redacted]/dL and home BP averages hover near 135/85?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌⁠​​‌‍‍​‌⁠‍‌‌⁠​⁠‌‍‍‌‌‍​⁠‌‍‍‌‌‍​‌‌‍⁠‍‌‍​‌‌⁠​⁠‌⁠​⁠‌‍‍‌‌⁠​⁠‌⁠‌​‌‍​‌‌‍⁠‍‌⁠‌​​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠‌‌⁠⁠‌⁠‌​‌‍⁠⁠‌⁠​​‌‍‍‌‌‍​⁠​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‌​⁠​‍​⁠​​​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍​‌‌⁠‌⁠‌‌​‍‌‍⁠​​⁠‌‍‌​‍⁠‌⁠​⁠‌​​‍‌‍⁠⁠‌‍‌​‌‌​‍‌​‍⁠‌​‍‍‌‍‌⁠‌⁠​‍‌‍‍‍​‍​‍‌⁠⁠‌​​

I pitch a short ‘test drive’: 6–8 weeks of low‑dose rosuvastatin with a scheduled check, simple fridge card (‘call if new muscle pain or dark urine’), and a QR/link to the Mayo Statin Choice tool so they see absolute risk/benefit at home (https://statindecisionaid.mayoclinic.org/). If they still hesitate, I offer ezetimibe or twice‑weekly start and loop back to BP habits — would a quick ‘test drive’ script fit your clinic flow?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌⁠​​‌‍‍​‌⁠‍‌‌⁠​⁠‌‍‍‌‌‍​⁠‌‍‍‌‌‍​‌‌‍⁠‍‌‍​‌‌⁠​⁠‌⁠​⁠‌‍‍‌‌⁠​⁠‌⁠‌​‌‍​‌‌‍⁠‍‌⁠‌​​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‌​​⁠​⁠​⁠​​​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‌​⁠​‍​⁠​‍​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‌⁠⁠‌‍‍⁠‌⁠​‍‌⁠‍‌‌​‌‌‌‍⁠​‌⁠​‍‌‍‌‍‌‌​⁠‌‍​‍‌‌‌‍​⁠​‌‌​⁠⁠‌​‍​​⁠​‍‌​​‌​‍​‍‌⁠⁠‌​​

I turn your ACC/AHA output into a “risk receipt”: I hand them and portal-message a photo that says “statin lowers your 10‑yr risk from ~X% to ~Y%,” then send a 48‑hr nudge — “ok to start tonight?” — which sticks better than my 90‑second spiel. If they still hesitate, I offer twice‑weekly rosuvastatin as a bridge with a 4‑week check. @OP have you tried the portal nudge?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌⁠​​‌‍‍​‌⁠‍‌‌⁠​⁠‌‍‍‌‌‍​⁠‌‍‍‌‌‍​‌‌‍⁠‍‌‍​‌‌⁠​⁠‌⁠​⁠‌‍‍‌‌⁠​⁠‌⁠‌​‌‍​‌‌‍⁠‍‌⁠‌​​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‌​​⁠​⁠​⁠​​​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‌​⁠​‍​⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‌​‍‌⁠​⁠‌‌​‌‌‌‍‌‌‍⁠⁠‌⁠‌‌‌‍‍⁠​⁠​⁠‌‌​‍‌​​‌‌​‍⁠‌​​‍‌⁠​‍‌‌​‍‌⁠​​‌⁠‍​​‍​‍‌⁠⁠‌​​